Longitudinal analysis of T2 relaxation time variations following radiotherapy for prostate cancer.

Prostate cancer Quantitative MRI Radiation therapy T2 relaxation times Treatment response

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
30 Jan 2024
Historique:
received: 07 07 2023
revised: 02 12 2023
accepted: 10 01 2024
medline: 1 2 2024
pubmed: 1 2 2024
entrez: 1 2 2024
Statut: epublish

Résumé

Aim of this paper is to evaluate short and long-term changes in

Identifiants

DOI: 10.1016/j.heliyon.2024.e24557 PMID: 38298676 PMC: PMC10828070
pubmed: 38298676
doi: 10.1016/j.heliyon.2024.e24557
pii: S2405-8440(24)00588-7
pmc: PMC10828070
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e24557

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Pavla Hanzlikova (P)

Department of Radiology, University Hospital Ostrava, Czech Republic.
Department of Imaging Methods, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.

Dominik Vilimek (D)

Department of Cybernetics and Biomedical Engineering, Faculty of Electrical Engineering and Computer Science, VSB - Technical University of Ostrava, 17. listopadu 15, Ostrava - Poruba, 708 00, Czech Republic.

Radana Vilimkova Kahankova (R)

Department of Cybernetics and Biomedical Engineering, Faculty of Electrical Engineering and Computer Science, VSB - Technical University of Ostrava, 17. listopadu 15, Ostrava - Poruba, 708 00, Czech Republic.

Martina Ladrova (M)

Department of Cybernetics and Biomedical Engineering, Faculty of Electrical Engineering and Computer Science, VSB - Technical University of Ostrava, 17. listopadu 15, Ostrava - Poruba, 708 00, Czech Republic.

Valeria Skopelidou (V)

Institute of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava, 70852, Ostrava, Czech Republic.
Institute of Molecular and Clinical Pathology and Medical Genetics, Faculty of Medicine, University of Ostrava, 70300, Ostrava, Czech Republic.

Zuzana Ruzickova (Z)

Faculty of Medicine, University of Ostrava, 70300 Ostrava, Czech Republic.
Department of Oncology, University Hospital Ostrava, 70852 Ostrava, Czech Republic.

Radek Martinek (R)

Department of Cybernetics and Biomedical Engineering, Faculty of Electrical Engineering and Computer Science, VSB - Technical University of Ostrava, 17. listopadu 15, Ostrava - Poruba, 708 00, Czech Republic.

Jakub Cvek (J)

Faculty of Medicine, University of Ostrava, 70300 Ostrava, Czech Republic.
Department of Oncology, University Hospital Ostrava, 70852 Ostrava, Czech Republic.

Classifications MeSH